Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from COSCIENS Biopharma ( (TSE:CSCI) ) is now available.
COSCIENS Biopharma Inc. has announced its upcoming annual general and special meeting of shareholders, scheduled for June 30, 2025. This virtual meeting will cover several key agenda items, including the election of directors, appointment of auditors, and the reconfirmation of the Corporation’s Amended and Restated Shareholder Rights Plan Agreement. The meeting aims to enhance shareholder engagement by allowing participation via a live audio webcast, ensuring broader accessibility and interaction.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical and nutraceutical products. The company is known for its patented technologies and value-driving products, including oat-based pipeline products and Macrilen® (macimorelin), with a market focus on addressing unmet needs in the nutraceuticals sector.
YTD Price Performance: 25.45%
Average Trading Volume: 2,384
Technical Sentiment Signal: Sell
Current Market Cap: C$15.51M
See more data about CSCI stock on TipRanks’ Stock Analysis page.